Cargando…

An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yasamineh, Saman, Kalajahi, Hesam Ghafouri, Yasamineh, Pooneh, Yazdani, Yalda, Gholizadeh, Omid, Tabatabaie, Raheleh, Afkhami, Hamed, Davodabadi, Fatemeh, farkhad, Alireza Khanalipour, Pahlevan, Daryoush, Firouzi-Amandi, Akram, Nejati-Koshki, Kazem, Dadashpour, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/
https://www.ncbi.nlm.nih.gov/pubmed/36209089
http://dx.doi.org/10.1186/s12951-022-01625-0
_version_ 1784805316419911680
author Yasamineh, Saman
Kalajahi, Hesam Ghafouri
Yasamineh, Pooneh
Yazdani, Yalda
Gholizadeh, Omid
Tabatabaie, Raheleh
Afkhami, Hamed
Davodabadi, Fatemeh
farkhad, Alireza Khanalipour
Pahlevan, Daryoush
Firouzi-Amandi, Akram
Nejati-Koshki, Kazem
Dadashpour, Mehdi
author_facet Yasamineh, Saman
Kalajahi, Hesam Ghafouri
Yasamineh, Pooneh
Yazdani, Yalda
Gholizadeh, Omid
Tabatabaie, Raheleh
Afkhami, Hamed
Davodabadi, Fatemeh
farkhad, Alireza Khanalipour
Pahlevan, Daryoush
Firouzi-Amandi, Akram
Nejati-Koshki, Kazem
Dadashpour, Mehdi
author_sort Yasamineh, Saman
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nanotechnology could suggest practical solutions for usage in the fight against viral infection. Nanotechnology-based approaches can help in the fight against SARS-CoV-2 infection. Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have increased the speed of vaccine development and the efficiency of vaccines. As a result, the increased investigation into nanoparticles as nano-delivery systems and nanotherapeutics in viral infection, and the development of new and effective methods are essential for inhibiting SARS-CoV-2 infection. In this article, we compare the attributes of several nanoparticles and evaluate their capability to create novel vaccines and treatment methods against different types of viral diseases, especially the SARS-CoV-2 disease. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-9547679
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95476792022-10-10 An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19 Yasamineh, Saman Kalajahi, Hesam Ghafouri Yasamineh, Pooneh Yazdani, Yalda Gholizadeh, Omid Tabatabaie, Raheleh Afkhami, Hamed Davodabadi, Fatemeh farkhad, Alireza Khanalipour Pahlevan, Daryoush Firouzi-Amandi, Akram Nejati-Koshki, Kazem Dadashpour, Mehdi J Nanobiotechnology Review Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nanotechnology could suggest practical solutions for usage in the fight against viral infection. Nanotechnology-based approaches can help in the fight against SARS-CoV-2 infection. Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have increased the speed of vaccine development and the efficiency of vaccines. As a result, the increased investigation into nanoparticles as nano-delivery systems and nanotherapeutics in viral infection, and the development of new and effective methods are essential for inhibiting SARS-CoV-2 infection. In this article, we compare the attributes of several nanoparticles and evaluate their capability to create novel vaccines and treatment methods against different types of viral diseases, especially the SARS-CoV-2 disease. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-10-08 /pmc/articles/PMC9547679/ /pubmed/36209089 http://dx.doi.org/10.1186/s12951-022-01625-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Yasamineh, Saman
Kalajahi, Hesam Ghafouri
Yasamineh, Pooneh
Yazdani, Yalda
Gholizadeh, Omid
Tabatabaie, Raheleh
Afkhami, Hamed
Davodabadi, Fatemeh
farkhad, Alireza Khanalipour
Pahlevan, Daryoush
Firouzi-Amandi, Akram
Nejati-Koshki, Kazem
Dadashpour, Mehdi
An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title_full An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title_fullStr An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title_full_unstemmed An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title_short An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19
title_sort overview on nanoparticle-based strategies to fight viral infections with a focus on covid-19
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547679/
https://www.ncbi.nlm.nih.gov/pubmed/36209089
http://dx.doi.org/10.1186/s12951-022-01625-0
work_keys_str_mv AT yasaminehsaman anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT kalajahihesamghafouri anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT yasaminehpooneh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT yazdaniyalda anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT gholizadehomid anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT tabatabaieraheleh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT afkhamihamed anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT davodabadifatemeh anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT farkhadalirezakhanalipour anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT pahlevandaryoush anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT firouziamandiakram anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT nejatikoshkikazem anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT dadashpourmehdi anoverviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT yasaminehsaman overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT kalajahihesamghafouri overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT yasaminehpooneh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT yazdaniyalda overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT gholizadehomid overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT tabatabaieraheleh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT afkhamihamed overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT davodabadifatemeh overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT farkhadalirezakhanalipour overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT pahlevandaryoush overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT firouziamandiakram overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT nejatikoshkikazem overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19
AT dadashpourmehdi overviewonnanoparticlebasedstrategiestofightviralinfectionswithafocusoncovid19